tru Independence’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,359
Closed -$264K – 349
2021
Q1
$264K Hold
1,359
– – 0.05% 215
2020
Q4
$260 Buy
+1,359
New +$247K ﹤0.01% 415
2020
Q3
– Sell
-1,006
Closed -$124K – 735
2020
Q2
$124K Buy
+1,006
New +$118K 0.02% 283

Other funds holding RGEN

tru Independence's RGEN Position: Q2 2021 in Review

tru Independence sold out of Repligen (RGEN) in Q2 2021, closing a stake of 1,359 shares — an estimated $264K sold.

tru Independence first reported a position in RGEN in Q2 2020 and held it in 3 quarters. The position peaked at $264K in Q1 2021. 429 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • tru Independence reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • tru Independence sold 1,359 Repligen shares in Q2 2021, an estimated $264K.
  • tru Independence first reported a position in Repligen in Q2 2020 and held it in 3 quarters.
  • tru Independence's Repligen position peaked at $264K in Q1 2021.
  • 429 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on tru Independence's 13F filing for Q2 2021, filed 3 Aug 2021.